Detail page

Knowledge Web

Person

Stefan Hubert Leggewie (1967-)

Apotheker

Name	Stefan Hubert Leggewie
Time	1967- (Date of birth and death)
Profession	Apotheker (characteristic profession)
Further information	Apotheker, Arzt
Record type	Person
GND-Identifier	129374873
Record ID	129374873
Involved in show all D-dimer and fibrinogen indicate ischemic risk in patients with atrial fibrillation after percutaneous coronary intervention Low on-clopidogrel ADP- and TRAP-6-induced platelet aggregation in patients with atrial fibrillation undergoing percutaneous coronary intervention: an observational pilot study Thrombelastography compared with multiple impedance aggregometry to assess high on-clopidogrel reactivity in patients with atrial fibrillation undergoing percutaneous coronary intervention Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES trial Effect of alirocumab on mortality after acute coronary syndromes : : an analysis of the ODYSSEY OUTCOMES randomized clinical trial Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial Risk categorization using New American College of Cardiology / American Heart Association Guidelines for cholesterol management and its relation to alirocumab treatment following acute coronary syndromes Bedeutung des kardialen Endothelinsystems für die Pathogenese der linksventrikulären Dysfunktion am Modell der transgenen (mRen2)27-Ratte

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Stefan Hubert Leggewie (1967-)

D-dimer and fibrinogen indicate ischemic risk in patients with atrial fibrillation after percutaneous coronary intervention

Low on-clopidogrel ADP- and TRAP-6-induced platelet aggregation in patients with atrial fibrillation undergoing percutaneous coronary intervention: an observational pilot study

Thrombelastography compared with multiple impedance aggregometry to assess high on-clopidogrel reactivity in patients with atrial fibrillation undergoing percutaneous coronary intervention

Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome

Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES trial

Effect of alirocumab on mortality after acute coronary syndromes : : an analysis of the ODYSSEY OUTCOMES randomized clinical trial

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

Risk categorization using New American College of Cardiology / American Heart Association Guidelines for cholesterol management and its relation to alirocumab treatment following acute coronary syndromes

Bedeutung des kardialen Endothelinsystems für die Pathogenese der linksventrikulären Dysfunktion am Modell der transgenen (mRen2)27-Ratte